Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia

BACKGROUND: Visceral leishmaniasis (VL) is a protozoan disease that is invariably fatal if left untreated. The disease is found in 70 countries with incidence of 0.2 – 0.4 million cases. The mainstay of treatment in resource limited countries like Ethiopia is antimonials, while use of liposomal amph...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamiru, Aschalew, Tigabu, Bethlehem, Yifru, Sisay, Diro, Ermias, Hailu, Asrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057416/
https://www.ncbi.nlm.nih.gov/pubmed/27724891
http://dx.doi.org/10.1186/s12879-016-1746-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057416/
https://www.ncbi.nlm.nih.gov/pubmed/27724891
http://dx.doi.org/10.1186/s12879-016-1746-1

Ejemplares similares